Implication of PHF2 Expression in Clear Cell Renal Cell Carcinoma

• Published in: Journal of pathology and translational medicine Vol. 51; no. 4; pp. 359 - 364
• Main Authors: Lee, Cheol, Kim, Bohyun, Song, Boram, Moon, Kyung Chul
• Format: Journal Article
• Language: English
• Published: Korea (South) Korean Society of Pathologists, Korean Society for Cytopathology 01.07.2017; The Korean Society of Pathologists and the Korean Society for Cytopathology; Korean Society of Pathologists & the Korean Society for Cytopathology; 대한병리학회
• Subjects: Adipogenesis; Breast cancer; Carcinoma, renal cell; Clear cell renal cell carcinoma; Colorectal cancer; Cytoplasm; Epigenetics; Esophagus; Gastric cancer; Immunohistochemistry; Kidney cancer; Lipids; Medical prognosis; Multivariate analysis; Original; PHF2 protein, human; Proteins; Statistical analysis; Studies; Tumors; 병리학; Immunohistochemistry; Clear cell renal cell carcinoma; PHF2 protein, human; Carcinoma, renal cell; Adipogenesis
• ISSN: 2383-7837; 2383-7845
• DOI: 10.4132/jptm.2017.03.16

Clear cell renal cell carcinoma (CCRCC) is presumed to be associated with adipogenic differentiation. Histone modification is known to be important for adipogenesis, and the function of histone demethylase plant homeodomain finger 2 (PHF2) has been noted. In addition, PHF2 may act as a tumor suppressor via epigenetic regulation of p53 and is reported to be reduced in colon cancer and stomach cancer tissues. In this study, we examined PHF2 expression in CCRCC specimens by immunohistochemistry. We studied 254 CCRCCs and 56 non-neoplastic renal tissues from patients who underwent radical or partial nephrectomy between 2000 and 2003 at the Seoul National University Hospital. Tissue microarray blocks were prepared, and immunohistochemical staining for PHF2 was performed. Among 254 CCRCC cases, 150 cases (59.1%) showed high expression and 104 cases (40.1%) showed low expression. High expression of PHF2 was significantly correlated with a low Fuhrman nuclear grade (p < .001), smaller tumor size (p < .001), low overall stage (p = .003), longer cancer-specific survival (p = .002), and progression-free survival (p < .001) of the patients. However, it was not an independent prognostic factor in multivariate analysis adjusted for Fuhrman nuclear grade and overall stage. Our study showed that low expression of PHF2 is associated with aggressiveness and poor prognosis of CCRCC.